Literature DB >> 30442634

Paradoxical ulcerative colitis during treatment with secukinumab for psoriasis.

Shusuke Uchida1, Naoki Oiso1, Yoriaki Komeda2, Masatoshi Kudo2, Akira Kawada1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30442634     DOI： 10.1684/ejd.2018.3391

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  3 in total

1.  Inflammatory Bowel Disease Onset During Secukinumab Treatment: Real Concern or Just an Expression of Dysregulated Immune Response?

Authors:  Walter Fries; Alessandra Belvedere; Maria Cappello; Ambrogio Orlando; Gianluca Trifirò
Journal:  Clin Drug Investig       Date:  2019-08       Impact factor: 2.859

Review 2.  Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors.

Authors:  Keira A Fieldhouse; Samantha Ukaibe; Erika L Crowley; Reena Khanna; Ashley O'Toole; Melinda J Gooderham
Journal:  Drugs Context       Date:  2020-04-21

Review 3.  Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD.

Authors:  Irma Tindemans; Maria E Joosse; Janneke N Samsom
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.